Insider · CIK 0001253170
AKKARAJU SRINIVAS
Reports to the SEC for 31 companies · SOUTH SAN FRANCISCO, CA
Transactions
50
Companies
31
Filings
9
CIK
0001253170
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-08 | ALMSALUMIS INC.P Purchase | +$2.9M |
| 2026-09-08 | ALMSALUMIS INC.S Sale | −$507K |
| 2026-09-08 | ALMSALUMIS INC.P Purchase | +$2.9M |
| 2026-09-08 | ALMSALUMIS INC.S Sale | −$507K |
| 2026-09-04 | ALMSALUMIS INC.P Purchase | +$2.46M |
| 2026-09-04 | ALMSALUMIS INC.P Purchase | +$2.46M |
| 2026-06-30 | ALMSALUMIS INC.A Award | — |
| 2026-06-30 | ALMSALUMIS INC. · Stock Option (Right to Buy)A Award | — |
| 2026-06-26 | VTVTvTv Therapeutics Inc. · Director stock option (right to buy)A Award | +$210K |
| 2026-06-04 | SRRKScholar Rock Holding CorpA Award | — |
| 2026-06-04 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award | — |
| 2026-06-03 | KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-05-20 | KLRSKalaris Therapeutics, Inc.J Other | — |
| 2026-05-20 | KLRSKalaris Therapeutics, Inc.P Purchase | +$1.18M |
| 2026-05-20 | KLRSKalaris Therapeutics, Inc.J Other | — |
| 2026-05-20 | KLRSKalaris Therapeutics, Inc.J Other | — |
| 2026-02-19 | MLYSMineralys Therapeutics, Inc.A Award | — |
| 2026-02-19 | MLYSMineralys Therapeutics, Inc. · Stock OptionA Award | — |
| 2026-01-09 | ALMSALUMIS INC.P Purchase | +$10M |
| 2025-12-22 | KLRSKalaris Therapeutics, Inc.A Award | +$15M |
| 2025-12-18 | KLRSKalaris Therapeutics, Inc.P Purchase | +$5M |
| 2025-12-12 | SRRKScholar Rock Holding Corp · Warrants to Purchase Common StockX Exercise of In-Money | — |
| 2025-12-12 | SRRKScholar Rock Holding CorpX Exercise of In-Money | +$7.83M |
| 2025-12-05 | ALMSALUMIS INC.P Purchase | +$581K |
| 2025-12-05 | ALMSALUMIS INC.P Purchase | +$551K |
| 2025-12-05 | ALMSALUMIS INC.P Purchase | +$701K |
| 2025-12-04 | ALMSALUMIS INC.P Purchase | +$540K |
| 2025-12-03 | ALMSALUMIS INC.P Purchase | +$775K |
| 2025-12-02 | ALMSALUMIS INC.P Purchase | +$725K |
| 2025-12-01 | ALMSALUMIS INC.P Purchase | +$644K |
| 2025-11-28 | ALMSALUMIS INC.P Purchase | +$296K |
| 2025-11-26 | ALMSALUMIS INC.P Purchase | +$371K |
| 2025-11-20 | ALMSALUMIS INC.P Purchase | +$905K |
| 2025-11-19 | ALMSALUMIS INC.P Purchase | +$904K |
| 2025-11-18 | ALMSALUMIS INC.P Purchase | +$621K |
| 2025-11-17 | ALMSALUMIS INC.P Purchase | +$5,036.14 |
| 2025-11-13 | ALMSALUMIS INC.P Purchase | +$1.45M |
| 2025-10-07 | SRRKScholar Rock Holding CorpP Purchase | +$503K |
| 2025-10-07 | SRRKScholar Rock Holding CorpP Purchase | +$498K |
| 2025-10-07 | SRRKScholar Rock Holding CorpP Purchase | +$180K |
| 2025-10-06 | SRRKScholar Rock Holding CorpP Purchase | +$543K |
| 2025-10-06 | SRRKScholar Rock Holding CorpP Purchase | +$3.13M |
| 2025-10-06 | SRRKScholar Rock Holding CorpP Purchase | +$698K |
| 2025-10-03 | SRRKScholar Rock Holding CorpP Purchase | +$392K |
| 2025-10-03 | SRRKScholar Rock Holding CorpP Purchase | +$12M |
| 2025-10-03 | SRRKScholar Rock Holding CorpP Purchase | +$2.08M |
| 2025-09-22 | VTVTvTv Therapeutics Inc. · Pre-Funded Warrants (Right to Buy)A Award | — |
| 2025-09-22 | VTVTvTv Therapeutics Inc. · Warrant (Right to Buy)A Award | — |
| 2025-09-22 | VTVTvTv Therapeutics Inc.A Award | +$1.62M |
| 2025-09-04 | MLYSMineralys Therapeutics, Inc.P Purchase | +$15M |
Recent filings
- 4AKKARAJU SRINIVAS0001231919-26-001158SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001253170-26-000011SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001253170-26-000008SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001104659-26-071422SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001193125-26-257471SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001231919-26-000532SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001933414-26-000040SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001231919-26-000166SEC(opens sec.gov)
- 4AKKARAJU SRINIVAS0001253170-26-000004SEC(opens sec.gov)
Companies
- Aclaris Therapeutics, Inc.10% OwnerACRS
- ALIMERA SCIENCES INC10% Owner
- ALUMIS INC.DirectorALMS
- Aravive, Inc.Former Director
- aTYR PHARMA INCDirectorATYR
- BARRIER THERAPEUTICS INCDirector
- CARGO Therapeutics, Inc.10% Owner
- CHINOOK THERAPEUTICS, INC.Director
- Durata Therapeutics, Inc.10% Owner
- EYETECH PHARMACEUTICALS INCDirector
- ICAGEN INCMember of 10% owner group
- INTERCEPT PHARMACEUTICALS, INC.Director
- Jiya Acquisition Corp.Director, 10% Owner
- Kalaris Therapeutics, Inc.DirectorKLRS
- LENZ Therapeutics, Inc.10% OwnerLENZ
- Lite Strategy, Inc.10% OwnerLITS
- Mineralys Therapeutics, Inc.Director, 10% OwnerMLYS
- Neurogene Inc.10% OwnerNGNE
- Ocugen, Inc.10% OwnerOCGN
- Paratek Pharmaceuticals, Inc.Former 10% Beneficial Owner
- PHARMOS CORPDirector
- Principia Biopharma Inc.Director
- Scholar Rock Holding CorpDirectorSRRK
- Seagen Inc.Director
- Spark Therapeutics, Inc.10% Owner
- SYNAGEVA BIOPHARMA CORPFormer Director
- SYNLOGIC, INC.10% OwnerSYBX
- Syros Pharmaceuticals, Inc.Director
- vTv Therapeutics Inc.DirectorVTVT
- WORLD HEART CORP10% Owner
- ZS Pharma, Inc.Director
Address
C/O ALUMIS INC. 280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080